4//SEC Filing
Eliseev Alexey 4
Accession 0001209191-17-051978
CIK 0001533040other
Filed
Sep 6, 8:00 PM ET
Accepted
Sep 7, 8:17 PM ET
Size
9.2 KB
Accession
0001209191-17-051978
Insider Transaction Report
Form 4
Eliseev Alexey
Chief Business Officer
Transactions
- Sale
Common stock, par value $0.0001
2017-09-05$0.56/sh−26,181$14,585→ 1,100,931 total - Sale
Common stock, par value $0.0001
2017-09-06$0.54/sh−91,907$49,308→ 1,009,024 total - Sale
Common stock, par value $0.0001
2017-09-07$0.53/sh−58,712$31,018→ 950,312 total
Footnotes (4)
- [F1]The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]Represents the weighted average sale price. The lowest price at which shares were sold was $0.55 and the highest price at which shares were sold was $0.58.The reporting person hereby undertakes to provide upon request to the SEC staff or other appropriate persons full information regarding the number of shares and prices at which the transaction was effected.
- [F3]Represents the weighted average sale price. The lowest price at which shares were sold was $0.525 and the highest price at which shares were sold was $0.561.The reporting person hereby undertakes to provide upon request to the SEC staff or other appropriate persons full information regarding the number of shares and prices at which the transaction was effected.
- [F4]Represents the weighted average sale price. The lowest price at which shares were sold was $0.52 and the highest price at which shares were sold was $0.545.The reporting person hereby undertakes to provide upon request to the SEC staff or other appropriate persons full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
RXi Pharmaceuticals Corp
CIK 0001533040
Entity typeother
Related Parties
1- filerCIK 0001694380
Filing Metadata
- Form type
- 4
- Filed
- Sep 6, 8:00 PM ET
- Accepted
- Sep 7, 8:17 PM ET
- Size
- 9.2 KB